Three locations now recruiting: A Study of ZEN003694 in Combination With Enzalutamide in Patients Wi | RVX.TO Message Board Posts

Resverlogix Corp.

  RVX.TO website
  • Create your FREE account today!



    Username:Up to 23 characters, no spaces or apostrophes allowed.

    Password:6-20 characters.

    Confirm PasswordRetype Your Password.

    Email:You will receive an email to confirm this account,so please enter a valid address (and double cheek for typos!)


    I have read and agree to the InvestorVillage User Agreement.













RVX.TO   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  26293 of 26431  at  12/28/2016 2:34:50 AM  by

Fundamentals6


Three locations now recruiting: A Study of ZEN003694 in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer


https://clinicaltrials.gov/ct2/show/NCT02711956?term=zenith+epigenetics&rank=1


A Study of ZEN003694 in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer

Locations


United States, California

University of California Los Angeles Medical Center Recruiting
Los Angeles, California, United States

University of California San Francisco Medical Center Recruiting
San Francisco, California, United States

United States, Michigan

Karmanos Cancer Institute Not yet recruiting
Detroit, Michigan, United States

United States, New York

Memorial Sloan Kettering Cancer Center Recruiting
New York, New York, United States

United States, Oregon

Oregon Health & Science University Not yet recruiting
Portland, Oregon, United States

United States, Virginia

Virginia Oncology Associates Not yet recruiting
Hampton, Virginia, United States

Virginia Oncology Associates Not yet recruiting

Norfolk, Virginia, United States


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 3     Views: 147
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us    Contact Us    Follow Us on Twitter    Members Directory    Help Center    Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
2003-2016 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.

Loading...